A trader works on the floor of the New York Stock Exchange.

Check out which companies are making headlines before the bell:

Allergan–Allergan announced a deal to sell its generic drugs unit to Teva Pharmaceuticals for $40.5 billion in cash and stock. In a concurrent announcement, Teva said it had withdrawn its proposal to buy generic drug maker Mylan.